The 2024 intake for ophthalmology specialty training (OST) has undergone several significant changes in its approach towards candidate selection and assessment. This article provides a comparative analysis, detailing these new measures and comparing them against the previous year's standards. Our...
There are a growing number of statisticians working closely with ophthalmologists. They have different training but they are driven by the same goal: to perform high quality evidence based clinical research [1,2]. In a perfect world we would simply conduct...
It all came from networking Doing volunteer work is an integral part of being a doctor. Helping and treating those in need without financial recognition embodies righteousness and a pure spirit. As healthcare providers, we have an unwritten duty to...
National eye health survey shows a third of UK are considering laser eye surgery but vast majority are unaware it is non-reversible and how it can affect night vision.
The RCOphth 2024 Annual Congress / #EyeConUK is coming up and you know what that means, we're teaming up again with Sohiab R Rufai for another #AspireOphth Competition!
#puppydogeyes Who can resist a pair of puppy dog eyes? It may be that no human can! A team of researchers discovered that dogs acquired a new forehead muscle, which is scanty or absent in wolves. This muscle is the...
Part 3: Clinical features, assessment and management (see also Part 2, and Part 1) As previously mentioned in this treatise [1] pituitary tumours are common, occur in all age groups and can present with anything from minimal visual symptoms to...
5 August 2020
| George Liu, Mehran Zarei-Ghanavati, Rawya A Diab, Mohamed Bahga Goweida, Hasan Naveed, Christopher Liu (Prof)
|
EYE - General
COVID-19 is forcing us to reconsider every aspect of life. The authors ask what future ophthalmic meetings could look like. The coronavirus disease COVID-19 pandemic disrupted ophthalmic conferences resulting in the cancellation of the majority of meetings in 2020, e.g....
1 June 2015
| Rita McLauchlan, D Armstrong, Konstantinos Balaskas, Sajjad Mahmood
|
EYE - Vitreo-Retinal
Intravitreal injections of the anti-vascular endothelial growth factor (anti-VEGF) agent ranibizumab, for the treatment of wet age-related macular degeneration (AMD) was approved by National Institute for Health & Care Excellence (NICE) in 2008 [1]. The Manchester Royal Eye Hospital (MREH),...
The business world tells us, “Know your why.” But increasingly, we live in a society where people think, “Why bother?” In this interview, David wants to know what makes Carrie MacEwen tick, and why she bothered to get involved locally,...